| 2023/03/30 15:30:02 | |
|---|---|
| Price | |
| 19.10 USD | |
| Difference | 30.42% (4.45) |
General attributes
| ISIN | US0042251084 |
| Symbol | ACAD |
| Exchange | London Stock Exchange |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 2,328 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 19.10 USD |
| High | 19.10 USD |
| Low | 19.10 USD |
| Close (prev. day) | 14.6454 USD |
| VWAP | 19.10 USD |
| Volume (pcs) | 195 |
| Trading volume | 3,724.50 |
| Number of trades | 1 |
| Last size | 195 |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2023/03/30 15:30:02 | |
|---|---|
| Price | |
| 19.10 USD | |
| Difference | 30.42% (4.45) |
General attributes
| ISIN | US0042251084 |
| Symbol | ACAD |
| Exchange | London Stock Exchange |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 2,328 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 19.10 USD |
| High | 19.10 USD |
| Low | 19.10 USD |
| Close (prev. day) | 14.6454 USD |
| VWAP | 19.10 USD |
| Volume (pcs) | 195 |
| Trading volume | 3,724.50 |
| Number of trades | 1 |
| Last size | 195 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 0.63 | 1.08 | 1.12 |
| Volatility | - | - | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | - USD (45) |
| Ø price 30 days | Ø volume 30 days (pcs.) | - USD (19) |
| Ø price 100 days | Ø volume 100 days (pcs.) | - USD (20) |
| Ø price 250 days | Ø volume 250 days (pcs.) | - USD (36) |
| YTD High | date | - USD (-) |
| YTD Low | date | - USD (-) |
| 52 Weeks High | date | - USD (-) |
| 52 Weeks Low | date | - USD (-) |
All listings for ACADIA PHARMACEUTICALS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/08/15 | 22:26 | 14.035 EUR | 0.00 | 1 |
| Stuttgart | 2024/08/16 | 18:44 | 13.855 EUR | 0.00 | 2 |
| Nasdaq | 2024/08/16 | 21:16 | 15.515 USD | 8.54 | 9,264 |
| Munich | 2024/08/16 | 08:08 | 13.94 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/03/30 | 15:30 | 19.10 USD | 0.00 | 1 |
| Frankfurt | 2024/08/16 | 08:58 | 13.935 EUR | 0.00 | 1 |
| Duesseldorf | 2024/08/16 | 19:31 | 14.005 EUR | 0.00 | 5 |
| Berlin | 2024/08/16 | 08:08 | 13.94 EUR | 0.00 | 1 |
Company Logo
Contact Details
| ACADIA PHARMACEUTICALS INC. |
| - - |
| Sorrento Valley Blvd. 3911 92121 San Diego, CA |
| Telefon: +1 (858) 558-2871 |
| Fax: +1 (858) 558-2872 |
| E-mail: info@acadia-pharm.com |
Company Profile
| - |
Members of Management Board
| Stephen Biggar | Chairman of Board of Directors |
| Adora Ndu | Member of Board of Directors |
| Edmund Harrigan | Member of Board of Directors |
| Elizabeth Garofalo | Member of Board of Directors |
| Daniel Soland | Member of Board of Directors |
| James Daly | Member of Board of Directors |
| Julian Baker | Member of Board of Directors |
| Laura Brege | Member of Board of Directors |